...
首页> 外文期刊>Chinese Medicine >Hepatoprotective properties of Penthorum chinense Pursh against carbon tetrachloride-induced acute liver injury in mice
【24h】

Hepatoprotective properties of Penthorum chinense Pursh against carbon tetrachloride-induced acute liver injury in mice

机译:Penthorum chinense Pursh对四氯化碳诱导的小鼠急性肝损伤的肝保护特性

获取原文

摘要

Penthorum chinense Pursh (Penthoraceae, PCP), a well-known Miao ethnomedicine, has been traditionally used to treat several liver-related diseases, such as jaundice and viral hepatitis. The aims of the present study were to evaluate the probable properties of the aqueous extract of PCP on carbon tetrachloride (CCl4)—induced acute liver injury in mice. C57BL/6 mice were orally administered an aqueous extract of PCP (5.15 and 10.3?g/kg BW) or silymarin (100?mg/kg) once daily for 1?week prior to CCl4 exposure. Silymarin serves as a positive drug to validate the effectivenes of PCP. A single dose of CCl4 exposure caused severe acute liver injury in mice, as evidenced by the elevated serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alanine phosphatase (ALP), and the increased TUNEL-positive cells in liver, which were remarkably ameliorated by the pretreatment of PCP. PCP was also found to decrease the levels of malondialdehyde (MDA), restore the glutathione (GSH) and enhance the activities of superoxide dismutase (SOD) and catalase (CAT) in the liver. In addition, the pretreatment of PCP inhibited the degradation of hepatic cytochrome P450 2E1 (CYP2E1), up-regulated the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and its target proteins in CCl4-treated mice. Results indicated that the pretreatment of PCP (10.3?g/kg BW) effectively protected against CCl4-induced acute liver injury, which was comparable to efficacy of silymarin (100?mg/kg). This hepatoprotective effects might be attributed to amelioration of CCl4-induced oxidative stress via activating Nrf2 signaling pathway.
机译:Penthorum chinense Pursh(Penthoraceae,PCP),一种著名的苗族人种医学,传统上用于治疗几种肝脏相关疾病,例如黄疸和病毒性肝炎。本研究的目的是评估PCP水提取物对四氯化碳(CCl4)诱导的小鼠急性肝损伤的可能特性。在暴露于CCl4之前,每天一次给C57BL / 6小鼠口服一次PCP(5.15和10.3?g / kg BW)或水飞蓟素(100?mg / kg)的水提取物,持续1周。水飞蓟素用作验证PCP有效性的阳性药物。单剂量暴露于CCl4会导致小鼠严重急性肝损伤,这可通过血清丙氨酸氨基转移酶(ALT),天冬氨酸氨基转移酶(AST)和丙氨酸磷酸酶(ALP)的升高以及肝脏中TUNEL阳性细胞的增加来证明,五氯苯酚的预处理明显改善了这些问题。还发现五氯苯酚可降低肝脏中的丙二醛(MDA)水平,恢复谷胱甘肽(GSH)并增强超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的活性。此外,PCP的预处理抑制了CCl4处理的小鼠肝细胞色素P450 2E1(CYP2E1)的降解,上调了核因子红系2相关因子2(Nrf2)及其靶蛋白的表达。结果表明,五氯苯酚的预处理(10.3μg/ kg体重)可以有效地防止CCl4引起的急性肝损伤,这与水飞蓟素(100μg/ kg)的疗效相当。这种肝保护作用可能归因于通过激活Nrf2信号通路改善了CCl4诱导的氧化应激。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号